OM Outset Medical Inc: רווח נקי למניה ב-12 החודשים האחרונים
Outset Medical, Inc. (OM) enjoys the trust of nephrologists thanks to its innovative Tablo device for home dialysis. Business efficiency relies on contract manufacturing of components and cloud-based monitoring. The active implementation of mobile blood purification systems simplifies patients' lives. The current level of the indicator is -3.90, which is demonstrated in detail by the eps TTM history.
%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%9C%D7%A9%D7%A0%D7%94%20%D7%9E%D7%AA%D7%92%D7%9C%D7%92%D7%9C%D7%AA&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_OM_-_Outset-Medical-Inc._-_Earnings-per-share-for-the-trailing-year "OM - רווח למניה בשנים עשר החודשים האחרונים Outset Medical, Inc. בטווח 04.07.2022 - 12.11.2026 | 👁️GURU.Markets👁️")
פילוחי מדדים פיננסיים ומדדי שוק עבור Outset Medical Inc (OM)
The proprietary Tablo system creates long-term growth potential, although regulatory complexities are temporarily limiting business scaling. By analyzing the TTM net income per share fundamental metric on the GURU.Markets platform, an investor can see the actual annual equity income adjusted for the impact of share issuance. This metric allows for the timely detection of margin compression and an assessment of the financial stability of Outset Medical, Inc. (OM) during periods of market volatility.
